Indeed, excessive treatment with the D2R blockers is known to induce extrapyramidal side effects including tardive dyskinesia [31,72], a movement disorder that shares the similar symptoms with DYT1 dystonia [73] whose mouse model shows the D2R–RGS imbalance toward RGS (Fig 2D). Here, PITX2 is linked to movement disorder.